The presence of HT was related with higher cumulative RAI activities administrated and higher number of radiometabolic therapies; also in this case, the reason could be related with the less efficacy of radioiodine to enter in the thyroid cells due to the inflammatory micro-environment and the loss NIS expression. This evidence concerns the gene SLC5A5 and hematocrit.